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http://dx.doi.org/10Hematopoietic cells (HPCs) develop from hemogenic endothelial cells (ECs), a specialized type
of ECs undergoing hematopoietic transition. However, the mesoderm origin for hemogenic
ECs or HPCs has not been clarified. To examine the origin for hemogenic mesoderm, we in-
activated Etv2, a master regulator for EC/HPC commitment, in specific regions. Region-
specific Etv2 ablation in early mesoderm caused local EC differentiation block, resulting in
the loss of specific vascular beds without compensatory migration of residual ECs into avas-
cular area. This feature of local EC/HPC differentiation block was correlated to the hemogen-
ic potential of each mesoderm subset. We found that caudal-lateral mesoderm of E7.5-8.5
embryos represent the pre-committed population critical for generating hemogenic ECs.
Etv2 ablation in caudal-lateral mesoderm by Hoxb6 Cre or Hoxb6CreER transgene affected
vitelline plexus formation and intra-aortic hematopoietic clusters. In differentiated embryonic
stem cells, this mesoderm subset marked by Hoxb6-lateral mesoderm promoter showed en-
riched T lymphopoietic potential among Flk-1+ cells, which could be regarded as a character-
istic for definitive HPCs. These findings indicate that critical mesoderm precursors possibly
for definitive type hemogenic ECs are regionally specified in primitive mesoderm, suggesting
that Hoxb6+ caudal-lateral mesoderm represents the critical source of HPCs, which are poten-
tially useful to enrich definitive HPCs from embryonic stem cells.  2013 ISEH - Society for
Hematology and Stem Cells. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Hematopoiesis proceeds from specialized endothelial cells
(ECs) termed hemogenic ECs [1], which are critical for
definitive hematopoiesis initiation in the aorta-gonado-
mesonephron (AGM) [2,3]. Despite the importance of he-
mogenic ECs, their origin has not been defined clearly.
Etv2/ER71 is a master regulator generating ECs and hema-
poietic cells (HPCs) from mesoderm [4]. Etv2 deficiency
causes complete EC and HPC loss in mouse embryos and
differentiated embryonic stem (ES) cells [5–7]. We
reasoned that Etv2 should provide a better clue than other
candidate genes to evaluate the contribution of mesoderm
subset into hemogenic ECs and HPCs.: Hiroshi Kataoka and Shin-Ichi Nishikawa, Labora-
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.1016/j.exphem.2013.02.009Flk-1 is a major signaling receptor for vascular endothe-
lial growth factor crucial for ECs and HPCs development
[8]; however, a small number of ECs and HPCs develop
even from Flk-1 null ES cells [9]. Moreover, Flk-1 is
required for multiple aspects of EC function even after
differentiation, including migration, proliferation, and EC
versus HPC fate determination. Therefore, deletion of
Flk-1 will complicate the interpretation of any phenotype
after deletion in a specific mesoderm. Indeed, Flk-1 dele-
tion in differentiated ECs by Tie-2Cre transgene causes
severe endothelial defect because of its requirement
throughout development [10].
Runx1 is dispensable for EC development, but indis-
pensably required for the EC-HPC transition. Runx1 dele-
tion in ECs results in defective hematopoiesis, whereas
deletion in CD45þ/vascular endothelial (VE) cadherin
compartment did not affect hematopoiesis [2,11]. Despite
its critical requirement for hematopoiesis, our results in
conditional Runx1 deletion using Hoxb6, Hes7, and
Mesp1Cre transgenes suggest that in region-specificby Elsevier Inc. Open access under CC BY-NC-ND license.
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can recover fetal liver CD45þ or KSL cells. This occurs
because Runx1 deficiency does not affect EC differentia-
tion and fundamental vascular bed formation, which
might allow integration of residual Runx1 expressing cells
to sites appropriate for hematopoiesis such as AGM or
umbilical vessels. Because Hoxb6, Hes7, and Mesp1Cre
transgenes might not completely delete Runx1 in all
ECs, those region-specific Runx1 deficient embryos can
expand HPCs from a small number of ECs that escaped
Runx1 excision. Therefore, it is difficult to clearly define
the mesoderm origin of hemogenic mesoderm based on
the phenotype analysis of regional Runx1 inactivation.
Scl is another candidate that is dispensable for EC differ-
entiation but required for HPC generation. The finding
that Tie-2Cre–mediated Scl deletion does not cause severe
HPC defect suggests its transient requirement like Etv2
[12]; however, because of its dispensability for EC devel-
opment, regional deletion of Scl using same Cre trans-
genes might allow compensation from unexcised cells as
observed in conditional Runx1 deletion.
In contrast to Flk-1 and Runx1, no vascular or hemato-
poietic defect was seen by Etv2 ablation by Tie-2 or Flk-1
Cre transgene in differentiated ECs (discussed later) [13],
demonstrating the transient Etv2 requirement only for EC
commitment. After transient expression, Etv2 is undetect-
able in differentiated HPCs, ECs of yolk sac (YS), AGM,
and major artery ECs after embryonic day (E) 10.5 [5]. To
investigate the critical mesoderm subset for hemogenic
ECs, we ablated Etv2 in a region-specific manner. Unlike
Runx1 conditional deletion, regional Etv2 inactivation
caused vasculature deficiency in specific areas without
compensatory EC migration from unaffected areas.Methods
Mice
Mox1-Cre (Y.S.) [43], Mesp1-Cre (Y.S.) [44], Sox1-Cre [45],
Hoxb6-Cre (R.K.) [46], Tie-2-Cre (M.Y.) [47], Hes7-Cre (R.K.)
[20], and Hoxb6-ERCre (S.M.) [48] lines were provided by
researchers listed in the Acknowledgments. ROSA26CreER mice
were from Jackson. Conditional Etv2 allele (Etv2fl) is detailed
in Supplementary Figure E1 (online only, available at www.
exphem.org). Cre transgenic mice crossed to Etv2 heterozygous
mice to generate Creþ/Etv2þ/ mice, were mated to Etv2fl/fl
mice to obtain tissue-specific knockout animals (e.g., Tie-2
Creþ/, Etv2þfl/- hereafter described Tie-2Etv2KO). ERCre was
activated by 4-OH tamoxifen (hereafter described Tmx) injection
into pregnant females as described previously [34].
Immunostaining and FACS analysis
Anti-CD31(MEC13.1; BD), anti-Flk-1(R&D Systems, Minneapo-
lis, MN, USA), anti-Runx1 (EPR3099; Epitomics, Burlingame,
CA, USA), and anti–c-Kit (ACK2, eBioscience; or goat poly-
clonal, R&D Systems, San Diego, CA, USA) were used as
primary immunostaining antibodies. FACS analysis and cell sort-
ing were performed using antibodies from Biolegend and AriaII(BD Bioscience, San Diego, CA, USA). Cre in situ hybridization
was performed as described previously [49].
Hoxb6 locus reporter ES cells
Hoxb6 lateral mesoderm promoter–enhancer [42,50] was used to
drive RFP or Venus reporter in ES cells (see legend for
Figure 7) [51]. Microarray and quantitative polymerase chain
reaction (PCR) analysis using indicated primers (Supplementary
Table 1, online only, available at www.exphem.org) were per-
formed as described previously [5].
Cell culture
Explant culture from early somite stage embryos was performed
as described previously [34]. In brief, caudal part of the embryo
proper or YS was explanted on OP9 for 2 days. Explants were
dissociated by 0.05% triplex (Invitrogen) and replated onto the
new OP9 layer in the presence of cytokines (stem cell factor,
100 ng/mL), erythropoietin (10 ng/mL), granulocyte colony-
stimulating factor (5 ng/mL), and interleukin (IL) 3 (5 U/mL) in
differentiation medium (Alpha-MEM with 10% FCS and 5 
104 mol/L 2-mercaptoethanol). For lymphocytes, IL-7 (10 ng/
mL) and Flt3-ligand (10 ng/mL) were used in the basal medium
described. ES cells were differentiated on OP9 cells, starting at
the cell density of 2  104 per 25 cm2 in differentiation medium.
T lymphocyte potential was examined as described [39], indi-
cating that this approach will reveal the regional hemogenic poten-
tial of primitive mesoderm.Results
Etv2 is dispensable after endothelial cell commitment
Etv2 expression is specific in Flk-1þ mesoderm and EC
precursors [5,14,15]; therefore, Tie-2Etv2KO mice were
generated to determine whether Etv2 is required in ECs.
Tie-2Etv2KO embryos showed normal vasculature
(Fig. 1A), getting liveborn animals with no obvious pheno-
types, suggesting that Etv2 is dispensable in ECs that
already have activated Tie-2 promoter. This suggestion is
consistent with the report that Etv2 deletion by Flk-1Cre
transgene showed no obvious defects [13]. We assumed
that ECs sufficiently differentiated to activate EC-specific
Cre transgenes do not require Etv2 for further vascular
development.
To analyze the Etv2 requirement timeframe, ROSAC-
reER/Etv2KO mice were analyzed after injecting Tmx at
different pregnancy dates. E8.5 (Fig. 1B) but not E9.5
(Fig. 1C) Tmx injection caused vascular defects, indicating
Etv2 dispensability beyond E9.5 after most ECs
differentiate.
Based on these results, Etv2 was ablated using
mice that express Cre in mesoderm by promoters indepen-
dent of EC/HPC differentiation. We used Mox1Cre and
Sox1Cre mice to probe the importance of somite or
neuronal lineage derived ECs. Although somite or
neuronal–neural crest lineages were reported to contribute
to ECs [16,17], neither Mox1 nor Sox1Etv2KO mice
Figure 1. Etv2 ablation in differentiated ECs does not create any vascular defects. (A) No obvious vascular defects in Tie-2Etv2KO embryos. Etv2 was
inactivated using EC-specific transgene Tie-2Cre. Tie-2Etv2KO embryos showed normal vascular development at E11.5. Tie-2Etv2KO embryos develop nor-
mally to 4 weeks of age without any obvious defects. Gross appearance of (a) control littermate and (b) Tie-2Etv2KO embryos. PECAM staining showed the
normal vascular patterning in both (c) control littermate and (d) Tie-2Etv2KO embryos.
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at the expected ratio (data not shown). This finding
suggests that ECs derived from somite or neuronal line-
ages are dispensable for vascular development, or
in these mutant mice Etv2 is ablated after EC
differentiation.
Etv2 ablation in broad mesoderm by Mesp1Cre caused
vascular defect sparing the posterior part of the
embryonic vasculature
Preceding results suggest that Etv2 ablation should
happen before and independently of EC differentiation
to evaluate the contribution of particular mesoderm to
specific vascular bed ECs. Therefore, we created Mes-
p1Etv2KO mice to delete Etv2 in broad mesoderm early
from the gastrulating stage (Supplementary Figure E2, on-
line only, available at www.exphem.org). Mesp1Etv2KO
embryos showed EC loss in broad areas including YS,
head region, anterior part of the embryo, and endocar-
dium, causing embryonic lethality at E9.5–10.5 (Fig.
2A–2E). Although the anterior part of the vasculature
including endocardial and cranial ECs is missing (Fig.
2C and 2D), embryonic vessels in the posterior region
were partly maintained (Fig. 2D). Nevertheless, in Mes-p1Etv2KO embryos, most caudal vasculature including
vitelline plexus was poorly developed (Fig. 2D, arrow
heads). It is noteworthy that little or no compensatory
EC migration into avascular zone happens in Mes-
p1Etv2KO embryos.
In E8.5 Mesp1Etv2KO embryos, dorsal aorta including
the posterior part is poorly developed (Supplementary
Figure E3, online only, available at www.exphem.org).
Because the posterior part of the embryo proper is not
the target of Mesp1Cre at E8.5 (Supplementary
Figure E2, online only, available at www.exphem.org),
this finding suggests that a significant proportion of aortic
ECs at E8.5 are supplied from extraembryonic or lateral
mesoderm. Despite extensive loss of extraembryonic
ECs, the finding that the posterior aorta is partly formed
at E9.5 also supports the notion that aorta ECs can be
generated from intraembryonic mesoderm that escaped
Cre excision [18] (Supplementary Figure E2, online
only, available at www.exphem.org). Cell tracing using
PDGFRa or Hes7 MerCreMer knock-in mice revealed
that E7.5–E8.0 paraxial cells give rise to ECs in the
embryo proper (H. Kataoka, unpublished results).
In Mesp1Etv2KO embryos, a few EC precursors that
escaped Etv2 deletion were distributed over YS as spots
Figure 1. (continued). (B, C) Embryonic cell differentiation defect in ROSACreEREtv2KO embryos depends on the timing of Etv2 deletion by Tmx injec-
tion. Etv2 was inactivated in ROSACreEREtv2KO embryos by injecting Tmx at different time points. Embryos were analyzed approximately at E10.5 by
PECAM staining. (B) Etv2 deletion at E8.5 caused similar EC defects observed either in global Etv2 null or Mesp 1 Etv2KO embryos. (a-c) Control litter-
mate, (d-f) ROSACreEREtv2KO(TmxE8.5). (C) Etv2 inactivation at E9.5 had little effect on EC differentiation in both embryo proper and yolk sac. (a-c)
Control littermate, (d-f) ROSACreEREtv2KO(TmxE9.5). Scale bar5500mm.
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adhesion molecule (PECAM)-stained sacs contained
round HPCs, suggesting that individual YS mesoderm
cells can generate both ECs and HPCs.Etv2 ablation in caudal-lateral mesoderm leads to
vascular and hematopoietic defect
Results inMesp1KOEtv2 embryos suggest that Etv2 ablation
in the early mesoderm is useful to probe local EC/HPC
Figure 2. EC loss and vascular defects in YS and embryo proper by Mesp1Cre mediated Etv2 deletion. Compared with the control littermate (A), Mes-
p1Etv2KO embryos (B) were smaller and pale at E9.5. In contrast to the control embryo (C), PECAM staining revealed the complete loss of ECs in Mes-
p1Etv2KO embryos (D) in the anterior part of the embryo proper, saving the posterior part of the vasculature and reflecting the excision pattern by Mesp1Cre
mice at E8.5 (see Supplementary Figure E2, online only, available at www.exphem.org). Note the incomplete development of the caudal part of the vascu-
lature including the vitelline plexus (arrowheads in D). Mesp1Etv2KO embryos showed extensive EC loss over the YS and anterior part of the vasculature
(E). Despite the extensive loss of ECs rostral to the cardiac region, ECs lining the cardiac outflow escaped excision (F, arrowheads). (G, H) YS residual EC
precursors form cystic structure in Mesp1Etv2KO embryos. In contrast to the normal vasculature formation in control embryo (G), few residual mesoderm
cells that escaped Etv2 deletion formed cystic structure with occasional HPCs inside (H).
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compensatory migration of residual ECs into the avascular
area was observed. However, Mesp1Cre transgene works in
broad mesoderm (Fig. 2; Supplementary Figure E2, online
only, available at www.exphem.org), making it difficult to
specify the mesoderm subset critical for hematopoiesis.
Accordingly, other region-specific Cre mice were used.
Hoxb6 promoter drives Cre in lateral mesoderm (LM) and
caudal part of embryos, resulting in Cre excision in LM,
YS, and caudal part of the embryo proper (Supplementary
Figure E4A, online only, available at www.exphem.org).
Hoxb6Etv2KO embryos looked anemic (Fig. 3A, a, b) at
E10.5 and failed to survive beyond E12.5. Those mutant
embryos showed EC loss in the caudal part of the embryo
proper with less organized and sparse vitelline plexus
(Fig. 3A, e–h). Presumably owing to the time delay of Cre
excision relative to EC differentiation, YS ECs were main-
tained in Hoxb6Etv2KO embryos (Fig. 3A, c, d). An anemic
phenotype in Hoxb6Etv2KO embryos (Fig. 3A, a, b) indi-
cated hematopoietic defect despite limited vascular defects
in the caudal part of the embryo proper, suggesting the impor-
tance of caudal-lateral primitivemesoderm to produceHPCs.
To specify the timeframe of Cre activity, Hoxb6C-
reER transgenic mice (Supplementary Figure E4B–D,online only, available at www.exphem.org) were used.
By Tmx injection around E8.0, Hoxb6CreER transgene
induces Cre excision in caudal-LM containing the cell
population giving rise to ventral side AGM ECs and
fetal liver Kitþ/Sca-1þ/Lineage– (KSL) cells
(Supplementary Figures E4C, E4D, online only, available
at www.exphem.org). Hoxb6CreEREtv2KO (Tmx E8.0)
embryos (Cre activated by E8.0 Tmx injection) looked
pale, showing similar defects in caudal vessels as seen
in Hoxb6Etv2KO at E10.5 (Supplementary Figure E3B,
a, b, e, f, g, online only, available at www.exphem.
org) and growth arrested at E12.5 without visible fetal
liver formation (Fig. 3B, c, d), suggesting failed hemato-
poiesis. Tmx injection at E7.5 or E8.5 recapitulated
similar phenotypes (data not shown). To support hemato-
poietic defect, Runx1 staining in umbilical cord was
much fainter in both Hoxb6Etv2KO and Hoxb6CreER-
Etv2KO (Tmx E8.0) embryos than in control
(Fig. 6A). Tmx injection at E7.0 or E9.0 caused little
hematopoietic defect as embryos developed to E12.5–
E13.5 with detectable fetal liver KSL cells. Because
Tmx activity was reported to decline to approximately
20% at 24 hours after injection [19], results from
Hoxb6CreEREtv2KO embryos help to narrow the critical
Figure 3. Hoxb6Cre or Hoxb6CreER causes vascular defects in caudal-ventral vasculature leading to hematopoietic defects. (A) Compared with the control
littermate (a), Hoxb6Etv2KO (b) embryos were anemic at E10.5. Although YS including lateral mesoderm is the target of Hoxb6 Cre transgene, presumably
because of the delayed Etv2 inactivation, YS ECs develop indistinguishably in control littermate (c) and Hoxb6Etv2KO (d) embryos. Caudal vasculature,
including vitelline plexus, is poorly developed in Hoxb6Etv2KO embryos (f, h). Note that the vessel defect is confined to the caudal part of the embryo
proper. (e, g) Control littermate. (f, h) Hoxb6Etv2KO. Scale bar5 500 mm. (B) Hoxb6CreEREtv2KO embryos showed a phenotype similar to Hoxb6Etv2KO
upon Cre activation with E8.0 Tmx injection. Compared with the control littermate (a), Hoxb6CreEREtv2KO (E8.0Tmx) (b) embryos were pale at E10.5.
Etv2 inactivation in Hoxb6 domain at E8.0 led to embryonic lethality at approximately E12.5. Compared with the control littermate (c), Hoxb6CreEREtv2KO
(E8.0 Tmx) (d) embryos were pale and almost absorbed at this stage. Similar to Hoxb6Etv2KO embryos, PECAM staining revealed that Hoxb6CreEREtv2-
KO (E8.0 Tmx) embryos showed the caudal part vascular defect. (e) Control littermate. (f, g) Hoxb6CreEREtv2KO (E8.0 Tmx). Scale bar 5 500 mm.
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E7.5–E8.5 (Supplementary Figure E4B, online only,
available at www.exphem.org). The domains where
Hoxb6 promoter–enhancer drives Cre transgene
(Supplementary Figure E4B, online only, available at
www.exphem.org) and the time frame of Tmx activity
duration, the caudal-LM at E7.5–E8.5 will be the critical
mesoderm subset causing hematopoietic defects because
of the failure to generate hemogenic ECs. This notion
can also be supported by the observation that approxi-
mately 50% of fetal liver B or KSL cells are labeled
by E8.0 Cre activation in Hoxb6CreER;ROSA-YFP-Rep
embryos (Supplementary Figure E4D, online only, avail-
able at www.exphem.org).
Etv2 deletion by Hes7Cre in embryo proper caudal
mesoderm caused local vascular and hematopoietic
defects
Hes7Cre transgenic mice were used to delete Etv2 specifi-
cally in caudal mesoderm. Hes7Cre mice express Cre trans-
gene in the posterior part of the embryo proper including
caudal somites and mesenchyme (Supplementary
Figure E5A, online only, available at www.exphem.org).
As reported previously [20], cells targeted by Hes7Cre
transgene distributed broadly over the posterior part of
the embryo proper (Supplementary Figure E5B, online
only, available at www.exphem.org). Despite this broad
distribution of target cells, and because of the narrow
time window of Etv2 requirement, Hes7Etv2KO embryos
showed vascular defects in the caudal part of the embryo
proper including the vitelline plexus (Fig. 4). Notably, He-
s7Etv2KO embryos were apparently anemic at E9.5–E10.5
(Fig. 4A and 4B), indicating the presence of hematopoietic
defect. Hematopoietic defects in Hes7Etv2KO embryos
were also supported by Runx1 staining and explant culture
(discussed later). Because Hes7Cre mice express Cre trans-
gene in caudal part of the embryo proper, this finding
suggests that contribution of the embryo proper caudal
mesoderm is important for the normal vasculature forma-
tion including vitelline plexus. This finding is consistent
with reports in zebrafish and mice [21,22] that the caudal
part of the embryo can be a source of multipotent meso-
derm giving rise to somite, neural, and endothelial cells.
Supporting this idea, virtually all adult bone marrow and
fetal liver KSL cells were derived from cells that receive
Cre excision by Hes7Cre transgene (Supplementary
Figure E5C, online only, available at www.exphem.org),
suggesting that hematopoietic stem cells (HSCs) originate
from caudal mesoderm or cells that exist transiently in
caudal area. HPC defect in Hes7Etv2KO embryos suggests
that caudal mesoderm is critical for hematopoiesis in part
by contributing to vitelline plexus. Alternatively, hemo-
genic mesoderm cells migrating into the caudal part of
the embryo proper might still need Etv2 to generate hemo-
genic ECs.Caudolateral mesoderm derived ECs are critical for the
generation of HPCs
Results in Hoxb6Etv2KO and Hoxb6EREtv2KO embryos
demonstrated that Etv2 inactivation in caudal LM (by
Hoxb6 LM promoter–enhancer) caused EC loss, leading
to defective hematopoiesis.
To evaluate the hemogenic potential, YS or p-Sp explant
was cultured from conditional knockout embryos (Fig. 5).
E8.25–E8.5 somite stage embryos were used because at
this stage YS and intraembryonic p-Sp can be anatomically
separable, and circulation has not been established, restrict-
ing the EC/HPC precursors where Etv2 is ablated by indi-
vidual Cre transgenes [3]. Moreover, Etv2 inactivation at
this stage (E8.25–E8.5) did not cause profound deleterious
effects on general embryonic development with normal
apparent morphology of each mutant.
YS explants from conditional Etv2KO embryos, except
Mesp1Etv2KO, developed HPCs indistinguishably from
control, indicating that YS hematopoiesis can be separable
from intraembryonic hematopoiesis (Fig. 5A). Despite
normal YS hematopoiesis, CD45þ HPC generation from
p-Sp explant was defective in Hoxb6 (including Hoxb6C-
reER [E8.0 Tmx]), and Hes7Etv2KO embryos (Fig. 5B),
indicating that the mesoderm targeted by these Cre trans-
genes contribute to p-Sp hematopoiesis. No CD19þ B
lymphocyte development was seen in p-Sp explants from
those mutant embryos (Supplementary Figure E6, online
only, available at www.exphem.org), suggesting that EC
precursors in the caudal part of lateral or embryo proper
mesoderm are critical for lymphopoiesis. In Mesp1Etv2KO
embryos, YS explant showed profoundly reduced hemato-
poiesis reflecting the extensive loss of YS EC/HPC precur-
sors (Fig. 5A, a). Mesp1Etv2KO p-Sp explant also showed
defective intraembryonic hematopoiesis despite partly
maintained posterior aorta at E9.5 (Fig. 2C and 2D). This
is presumably because in Mesp1Etv2KO embryos, Etv2 is
deleted in caudal LM, which contributes to intraembryonic
hemogenic ECs, as seen in hypoplastic aorta at E8.5
(Supplementary Figure E3, online only, available at www.
exphem.org).
Further supporting severe hematopoietic defects by
Etv2 inactivation in specific mesoderm, these mutants
showed significantly reduced Runx1þ cells in umbilical
vessels (Fig. 6A). Because Tmx can keep approximately
20% of maximum concentration 24 hours after injection
[19], we tried to narrow the time window critical for EC
and HPC differentiation in Hoxb6CreEREtv2KO
embryos. Hoxb6CreEREtv2KO embryos were exposed
to Tmx at E9.0 or E9.5 and examined at E12.5. Notably,
E12.5 Hoxb6CreEREtv2 embryos (Tmx at E9.0 or E9.5)
could develop fetal liver with indistinguishable KSL pop-
ulation from control embryos, indicating that Etv2 inacti-
vation in Hoxb6 area after E9.0 will not affect hemogenic
activity. We also confirmed that CreER activation by Tmx
injection at E7.0 failed to create a severe HPC defect in
Figure 4. Vascular defect in caudal part of the embryo by Hes7Etv2KO embryos. Compared with the control embryo (A), Hes7Etv2KO (B) embryos were
anemic. PECAM staining of control (C, E) and Hes7Etv2KO (D, F) embryos. Hes7 Etv2KO embryos are defective locally in the formation of caudal vascu-
lature, leaving YS vasculature intact (arrows in D). Higher magnification of the caudal part of the embryo proper shows defective caudal vasculature. In
addition to intersomatic vessels, note the disorganized vitelline plexus (arrowheads in F). Scale bar 5 500 mm.
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Figure 5. Compromised HPCs development from explants with Etv2 ablated in caudal-lateral mesoderm. Explant culture of p-Sp and YS from approxi-
mately E8.25 somite stage embryos was performed to evaluate the hemogenic potential of Mesp1, Hes7, Hoxb6, and Hoxb6ERCre (Tmx E8.0) Etv2KO
mutants. (A) YS explants from Mesp1 (upper panels in a), Hes7 (lower panels in a), Hoxb6 (upper panels in b), and Hoxb6ERCre (Tmx E8.0; lower panels
in b) Etv2KO mutants were cultured as described in the Methods. Except for Mesp1Etv2KO YS where extensive EC loss was seen, other mutant YS gener-
ated CD45þ HPCs indistinguishably from the control sample. (B) Explants of p-Sp region from Mesp1 (upper panels in a), Hes7 (lower panels in a), Hoxb6
(upper panels in b), and Hoxb6ERCre (Tmx E8.0) Etv2KO (lower panels in b) mutants showing that Etv2 ablation in those mutants severe reduction in the
generation of CD45þ HPCs. Proportions of CD45þKitþ cells generated from control explants and Hoxb6Etv2KO and Hoxb6ERCreEtv2KO collectively
showed a statistically significant difference (percent CD45þKitþ cells: control, 5.6% 6 3.6%; Hoxb6Etv2KO and Hoxb6ERCreEtv2KO, 0.05% 6
0.02%; p ! 0.05).
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Therefore, finding that Hoxb6CreEREtv2KO embryos
showed similar EC/HPC phenotype as Hoxb6Etv2KO by
Tmx injection around E8.0 (including E7.5 and E8.5)support the hypothesis that Hoxb6þ mesoderm in E7.5–
E8.5, corresponding to the time frame of Cre expression
in caudal LM-allantois (Supplementary Figure E4B, on-
line only, available at www.exphem.org), will be critical
Figure 6. HPC defects in region specific Etv2 deleted mutants analyzed by Runx1 or c-Kit immunostaining. (A) Runx1 staining of caudal part of
Hoxb6 (b), and Hoxb6ERCre (Tmx E8.0) (d), Mesp1 (f), Hes7 (h) Etv2KO embryos compared with the control littermates (a, c, e, g). Note that the
mutants with affected vitelline plexus also severely lack the Runx1þ cells in the umbilical cord. Scale bar 5 200 mm. (B) HPC clusters in AGM aorta
stained by c-Kit antibody was decreased in Hoxb6Etv2KO and Hoxb6CreEREtv2KO (TmxE8.0) embryos at E10.5. (a–c) Control. (d–f) Hoxb6Etv2KO.
(g–i) Control. (j–l) Hoxb6ERCre (Tmx E8.0) Etv2KO. (a, d, g, j) c-Kit. (b, e, h, k) PECAM. (c, f, i, l) Merged. Scale 5 100 mm. (C) Quantification of
c-Kitþ clusters observed in aorta lumen for Hoxb6Etv2KO (upper panel) and Hoxb6CreEREtv2KO (TmxE8.0; lower panel) embryos compared with
control littermates.
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577H. Kataoka et al./ Experimental Hematology 2013;41:567–581for hemogenic ECs. AGM region from E10.5 Hoxb6-
CreEtv2KO or Hoxb6CreEREtv2KO embryos was stained
for c-Kit and PECAM to visualize c-Kitþ HPCs in aorta.
In Hoxb6CreEtv2KO and Hoxb6CreEREtv2KO embryos,
luminal c-Kitþ clusters were significantly decreased (Fig.
6B and 6C), indicating the compromised intraaortic
hematopoiesis by Etv2 ablation in the caudal-
LM-allantois.
Hoxb6 expression by LM enhancer marks more
hemogenic mesoderm in in vitro differentiated ES cells
Mutant embryos analyzed indicate Hoxb6þ caudal-LM as
an important hemogenic source. Recently, virtually all
adult HPCs are shown to be descendants from Hoxb6þ
cells [23]. We reasoned that Hoxb6þ mesoderm marked
by Hoxb6 LM promoter–enhancer would be a suitable
source for HPCs in ES differentiation. Hoxb6-RFP or
Hoxb6-Venus ES cells were created to analyze Hoxb6þ
cells in differentiation culture (Fig. 7A, a, b). In Hoxb6
reporter ES cells differentiated for 6 days on OP9,
approximately 3% of Flk-1þ cells were Hoxb6-Venus or
RFPþ, indicating that the majority of Flk-1þ cells gener-
ated in vitro might not have the equivalent hemogenic
activity as embryonic Hoxb6þ mesoderm. Similar results
were obtained with embryoid body differentiation culture.
To characterize Flk-1þ/Hoxb6þ population, Flk-1þ/
Hoxb6– and Flk-1þ/Hoxb6þ cells were compared by
gene expression profiling (microarray and quantitative
PCR; Fig. 7B and 7C) and T lymphopoietic potential
analysis on OP9 cells (Fig. 7D). Several candidate genes
that are related to hematopoiesis or lymphocyte function
including Endou, Pou2af1, Il16, GIMAP family members,
TBATA, and TLR4 are upregulated in Hoxb6þ population
by microarray. Conversely, transcripts related to primitive
mesoderm such as Mesp1, Eomes, Gsc, Mixl1, and
PDGFRa or cardiomyocytes–muscle–somite lineages
including GATA4, Tbx5, Tbx20, Myh6, and Mesp2, were
downregulated in Flk-1þ/Hoxb6þ cells (Fig. 7B). Hoxb6þ
population expressed higher level of Sox17, Gata3,
Notch1, and Notch4, which are critical for definitive
hematopoiesis by quantitative PCR (Fig. 7C) [15,24–
28]. These results suggest that Flk-1þ/Hoxb6þ cells
have more hematopoietic potential, including lymphopoi-
esis that is regarded as one of the features of definitive
hematopoiesis.
To compare lymphopoietic potential, sorted Flk-1þ/
Hoxb6þ or Flk-1þ/Hoxb6– cells were cultured on OP9 or
OP9-DL1 cells to examine B or T cell generation, respec-
tively. Although B cells developed indistinguishably from
both Hoxb6þ and Hoxb6– populations on OP9 plus IL-7
and Flt3L condition (data not shown), T cells were gener-
ated at a higher frequency from Hoxb6þ cells (Fig. 7D).
These results demonstrate that the small Flk-1þ/Hoxb6þ
population among Flk-1þ cells could represent the popula-tion having more definitive hematopoietic character than
the Flk-1þ/Hoxb6 cells.
Discussion
Region-specific Etv2 ablation revealed that EC precursors
can be recruited locally to vascular segments from specific
mesoderm without compensatory migration of residual ECs
into the avascular area. This finding is consistent with the
report that anterior and posterior parts of the vasculature
develop separately, suggesting the segmental organization
of embryonic vasculature [29]. This segmental or local
EC recruitment from specific mesoderm was used to
examine the critical mesoderm for hematopoiesis. Condi-
tional Etv2 ablation has advantage over Flk-1 or Runx1
because Flk-1 is required in many aspects of EC function,
even in differentiated ECs, and incomplete Runx1 deletions
by region-specific Cre transgenes allow HPC recovery to
get almost normal liveborn mice (H. Kataoka, unpublished
results).
In contrast, region-specific Etv2 deletions suggest that
residual ECs that escaped Etv2 ablation are unlikely to
recover local vasculature to allow hemogenic cell migration
from other areas.
Hemogenic (including definitive) potentials of several
places have been tested by Cre-loxP–based cell tracing
or explant culture of anatomically separated tissues
[3,30–34]. However, the functional importance has not
been evaluated by local genetic ablation of potential
precursors. Etv2 will be suitable for this purpose because
Etv2 is only transiently required and is indispensable for
EC/HPCs.
Etv2 ablation by Hoxb6Cre or Hoxb6CreER (Tmx E8.0)
in caudal LM caused profound HPC defects. Hes7Etv2KO
embryos also showed that intraembryonic caudal mesoderm
at E7.5–E8.5 will be critical for hematopoiesis, although we
could not exclude the possibility that Hes7Cre is deleting
Etv2 in cells that migrate into the caudal part of embryo
proper from LM or allantois. Hoxb6Etv2KO, Hoxb6CreER-
Etv2KO, and Hes7Etv2KO embryos showed hematopoietic
defects, although ECs and hematopoiesis in YS were unaf-
fected, indicating that caudal-LM mesoderm distinct from
extraembryonic YS is critical for hematopoiesis.
Transient timeframe of Etv2 requirement helps to
narrow the critical hemogenic mesoderm, even with contin-
uous Cre transgene activity used for Etv2 deletion. As
demonstrated in Tie2Etv2KO and ROSACreEREtv2KO
embryos, Etv2 will not be required after E9.5. ROSA-
CreEREtv2KO (E9.5Tmx) embryos developed ECs and
HPCs from Etv2 inactivated cells (Supplementary
Figure E7, online only, available at www.exphem.org).
Moreover, in Hoxb6CreEREtv2KO embryos Cre activation
at E7.0 or E9.0 caused no severe hematopoietic defect with
KSL cells present in E12.5 fetal liver, indicating that the he-
mogenic mesoderm can be narrowed to E7.5–E8.5 Hoxb6þ
Figure 7. Hoxb6þ/Flk-1þ population represents mesoderm enriched for hemogenic potential. (A) Generation of Hoxb6-reporter ES cells. Hoxb6-3.6Kb
lateral-mesoderm promoter–enhancer was used to drive Venus (a) or RFP (b). Hoxb6-3.6Kb lateral mesoderm promoter–enhancer element was ligated to
RFP or Venus and inserted into PiggyBac (PB)-based expression cassette or hypoxanthine phosphoribosyltransferase (HPRT) locus knock-in vector (a
gift from Drs. S.A.Duncan and T.Morisaki) to create PB-Hoxb6-RFP reporter and pMP8OlacZ-Hoxb6-Venus targeting vectors, respectively. PB-
Hoxb6-RFP construct was introduced into TT2 ES cells with blasticidin selection plasmid at a ratio of 10:1 to select reporter construct introduced clones.
Knock-in vector pMP8OlacZ-Hoxb6-Venus was electroporated into Hprt deficient EB5 ES cells and selected in 1XHAT (Sigma-Aldrich, St. Louis, MO,
USA) medium. Reporter constructs were introduced into ES cells using a PB-based method or HPRT locus knock-in, obtaining similar results by both
methods. FACS analysis of Hoxb6 reporter ES cells differentiated for 6 days. Despite a significant amount of Flk-1þ cells, only a minor proportion
(w0.3%) of cells were Hoxb6þ/Flk-1þ in both RFP (a) and Venus (b) reporter systems. This Hoxb6þ/Flk-1þ population was CD45– but partly CD41lowþ,
expressing lower levels of EC markers such as VE-cadherin, ICAM-2, CD31, and Tie-2. Thus, the Hoxb6þ/Flk-1þ population represents the intermediate
state between Flk-1þ mesoderm and differentiated ECs or HPC precursors. (B, C) Gene expression profiling of Hoxb6–/Flk-1þ versus Hoxb6þ/Flk-1þ pop-
ulations by microarray and quantitative PCR. (B) RNAwas purified from sorted Hoxb6–/Flk-1þ and Hoxb6þ/Flk-1þ populations and subjected to microarray
analysis. Genes relevant for mesoderm and endothelial and hematopoietic development are listed.
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Figure 7. (continued). (C) Quantitative PCR analysis revealed upregulation of several genes known to be related to definitive hematopoiesis, such as Gata3,
Lmo2, Notch1, NOTCH4, and Sox17. Despite similar levels of Cdx4 expression, Hoxb4 and Hoxb6 were expressed at higher levels in Hoxb6+/Flk-1+ than in
Hoxb6-/Flk-1+ population, indicating the more posterior mesoderm character in Hoxb6+/Flk-1+ cells. (D) T cell generation from Hoxb6–/Flk-1þ versus
Hoxb6þ/Flk-1þ cells. Hoxb6/Flk-1þ or Hoxb6þ/Flk-1þ population was sorted. Varying numbers of cells from each population were seeded on OP9-
DL1 cells and cultured for 20 days. (a) Representative FACS analysis confirming T cell generation. (b) Calculated frequency of T cell generation is shown
for Hoxb6-/Flk-1þ and Hoxb6þ/Flk-1þ populations.
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HSCs origin [26].
In differentiated ES cells, Etv2 is required for the Tie-
2þc-Kitþ hemogenic ECs [7]; however, the role of Etv2
to generate hemogenic ECs during physiologic embryogen-
esis remains obscure.
Etv2 deficiency causes the loss of YS Flk-1þ mesoderm
and Runx1þ or Gata1þ cells, clearly demonstrating its
requirement for YS hematopoiesis [5].
Regarding AGM hematopoiesis, there is no detectable
Etv2 expression in AGM ECs in E10.5 Etv2-Venus
reporter embryos, suggesting that Etv2 is dispensablefor AGM hematopoiesis. Moreover, observations that
Tie-2Etv2KO or Flk-1Etv2KO embryos develop normally
suggest that Etv2 is dispensable for Runx1-dependent EC/
HPC transition. This view is consistent with the reports
that Runx1 might not be the direct target of Etv2
[13,35] and the development of KSL cells in ROSA-
CreEREtv2KO (E9.5 Tmx) embryos (Supplementary
Figure E7, online only, available at www.exphem.org).
However, we demonstrate that Hoxb6þ caudal–LM-
derived ECs, giving rise to the ventral side of aorta ECs
and vitelline plexus, are critically required for hematopoi-
esis. Etv2 requirement in Hoxb6þ mesoderm for AGM
580 H. Kataoka et al./ Experimental Hematology 2013;41:567–581hematopoiesis is also supported by a smaller number of c-
Kitþ cells in the aorta in Hoxb6Etv2KO or Hoxb6CreER-
Etv2KO embryos (Fig. 6B). We propose that for AGM
hematopoiesis, Etv2 is required in the initial induction
of hemogenic ECs but dispensable for EC-HPC transition.
Vitelline vasculature remodeling was reported to be
important for hematopoiesis [23]. Hoxb6 (and Hoxb6C-
reER) Etv2KO and Hes7Etv2KO embryos both showed
vitelline plexus defects leading to defective hematopoi-
esis. Poorly developed vitelline plexus was also observed
in Mesp1Etv2KO embryos, a possible reason for defective
hematopoiesis. Runx1 staining in umbilical vessel was
also severely decreased in Mesp1Etv2KO and He-
s7Etv2KO embryos (Fig. 6A, e–h). These results indicate
that caudal–LM-derived ECs contribute to the vitelline
plexus as well as ECs on the ventral side of dorsal aorta,
both of which seem to be critical for hematopoiesis.
Several locations other than LM or AGM are proposed
to have hemogenic potential [36,37]. Nevertheless, our
loss of function study by Etv2 ablation showed the critical
contribution of Hoxb6þ caudal-LM to hematopoiesis on
the embryo proper side. It is possible that some HPCs
are not directly derived from VE-cadherinþ ECs, but
from CD41þ/VE-cadherin– cells [25,38]. In any case,
Etv2 inactivation abolishes both VE-cadherin and
CD41þ cells, preventing HPC generation from mesoderm
[5]. Zovein et al. [23] also showed that the majority of
CD41þ cells related to vitelline vessels are the descen-
dants of VE-cadherinþ cells, which require Etv2 to
develop from mesoderm. The result that Etv2 inactivation
in specific primitive mesoderm causes hematopoietic
defects suggests that mesoderm cells are regionally pre-
committed to specific ECs or HPCs before differentiation.
Among Flk-1þ cells, features related to definitive hemato-
poiesis were found in Hoxb6þ/Flk-1þ over Hoxb6-/Flk-1þ
population. In vitro generation of transplantable HPCs is
successful by Hoxb4 overexpression, indicating that poste-
riorization Hox code might be important for in vitro hemato-
poiesis, possibly reflecting the embryonic origin of
hemogenic ECs. Recently, day 5 Flk-1þ population was
shown to be enriched for progenitors giving rise to T cells
than day 3 Flk-1þ cells [39]. Correlation between
T lymphocyte and definitive hematopoietic potentials was
further supported in human ES [40]. Thus, Flk-1þ/Hoxb6þ
cells having features for definitive HPCs and higher T lym-
phopoietic potential might be a suitable hemogenic popula-
tion for in vitro HPC induction (Fig. 7). Wnt family
proteins, especially Wnt16, are important for hematopoiesis
in zebrafish [41]. Hoxb6þ LM is located on the caudal part of
the embryo close to the expression domain of Wnt16 [42].Conclusions
Etv2 was ablated in a region-specific manner to define the
critical mesoderm for hematopoieses. We propose thatE7.5-8.5 Hoxb6þ caudal-lateral mesoderm including allan-
tois is critical for intraembryonic (possibly definitive)
hematopoieses. Hoxb6þ mesoderm will also be useful for
in vitro HPC generation from ES cells.Acknowledgments
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Supplementary Figure E1. Generation of Etv2 conditional allele (Etv2fl). Targeting vector was constructed using pFrtNeo (Addgene) with homology arms
(5ʹ side, nucleotide sequence 17902-24302 and 3ʹ side, 24319-26384 of RP23-72M20, AC167978.4). Two loxP sites were placed at nucleotide positions
23505 and 24318 of RP23-72M20 (AC167978.4). After Cre recombination between these two loxP sites, the resulting allele lacks the DNA binding domain
of Etv2, equivalent to the reported functionally null allele created using ES cell line (141.1H7). Constructed vector was electroporated into TT2 ES cells, and
G418 resistant clones were screened for the right recombination. Genotyping of the Etv2fl allele was performed by a set of primers: Etv2Fwd 12370, gtctga-
tagagccacattgactcgctactcc; Etv2Rev 12906, gcagctccaggaggaattgccacagctg; and Etv2LoxP12705Fwd, ctatggaggaattctgatatcgataacttcg; wild type, 530 bp; fl,
200 bp. Cre recombination event can be detected by primers: Etv2-12384Fwd, gaggtaagaggctgcaaactgcagaagagg; and Etv2-13614Rev, cactcatagtgaaatggcctt-
gatggtcgtc; wild type, 1200 bp; loxP sites recombined, 400 bp.
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Supplementary Figure E2. Mesp1Cre mice were crossed with ROSALacZ reporter line mice. Embryos were LacZ stained at E8.5 and E9.5 to visualize the
cells that received Cre excision. At E8.5, LacZ positive cells are distributed broadly in the extraembryonic and intraembryonic regions (A). Note, however,
that the posterior part of the embryo proper is escaping Cre excision (arrows) (B). At E9.5, LacZþ cells distribute throughout YS and the embryo proper with
intense staining in the cardiac tissue (C, D).
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Supplementary Figure E3. Defective development of aorta in E8.5 Mesp1Etv2KO embryos. Control (A, D) and Mesp1Etv2KO embryos (B, C, E, F) were
stained for Flk-1 to visualize ECs lining along the aorta contour. Note that in Mesp1Etv2KO embryos ECs were lost in extraembryonic mesoderm and barely
detectable in the posterior part of the dorsal aorta. (A–C) Anterior view. (D–F) Posterior view. Scale bar 5 500 mm.
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Supplementary Figure E4. (A) Hoxb6 Cre mice were crossed with ROSA LacZ reporter line. Hoxb6 Cre transgene induces excision in lateral mesoderm,
YS, allantois, and the caudal part of the embryo proper. (B) Analysis of Hoxb6 ERCre transgenic mice. In situ hybridization using Cre probe to reveal the
expression domain of ERCre transgene driven by Hoxb6 promoter in E7.5 (a, b), E8.5 (c, d), and E9.0 (e) embryos. In situ hybridization for Cre was per-
formed using Cre probe PCR amplified from Cre cDNA by primers (5ʹ-atggcacccaagaagaagaggaaggtgtcc-3ʹ and 5ʹ-ccaggttacggatatagttcatgac-3ʹ).
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Supplementary Figure E4. (continued). (C, D) Tracing of labeled cells in Hoxb6CreER; ROSA-LacZ or YFP reporter mice by (C) Tmx injection at E8.0.
In LacZ reporter mice, Cre activation by E8.0 Tmx injection labeled ECs on the ventral side of aorta at E11.5, indicating the contribution of labeled cells to
hemogenic ECs. (D) Fetal liver cells from E14.5 Hoxb6CreER. ROSA-YFP embryos (Tmx E8.0) were analyzed. More than 50% of B cells or KSL cells are
YFPþ, suggesting that lateral-caudal mesoderm at E8.0 contributes to definitive HPCs.
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Supplementary Figure E5. (A) Hes7 promoter drives Cre transgene expression in caudal part of the embryo proper. Cre expression starts around proximal
primitive streak and continues in the caudal part of the embryo proper, consistent with the previously reported Hes7 expression. (B) Hes7Cre mice were
crossed with ROSALacZ reporter line. E8.5, E9.5, and E10.5 embryos were LacZ stained to trace the Cre target cells. Hes7 Cre induces excision in posterior
part of the embryo proper but not in the extraembryonic region. Hes7 Cre target cells also contribute the umbilical cord. (C) FACS analysis showing that
Hes7Cre labeled cells contribute to fetal liver KSL and covers almost all HPCs in adult. Hes7Cre mice were crossed with ROSA YFP reporter line. E14.5
embryo fetal liver cells and adult bone marrow were analyzed for the contribution of YFPþ cells that received Cre excision.
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Supplementary Figure E6. Defective B cell generation from explants from Mesp1, Hes7, Hoxb6, and Hoxb6ERCre (Tmx E8.0) Etv2KO embryos.
Compared with the control explant (embryo proper caudal part), each mutant lacking EC precursors from caudal-lateral mesoderm failed to develop B
lymphocytes.
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Supplementary Figure E7. Etv2 inactivation at E9.5 does not block EC and HPC differentiation. Etv2 was ablated in ROSACreEREtv2KO embryos by
E9.5 Tmx injection. ECs and HPCs were analyzed at E12.5. To monitor the cells that received Cre excision, mice were crossed into the ROSA-YFP reporter
line. (A) Comparable proportions of CD45þ HPCs and VE-cadherin (VECAD)þ ECs were present as YFPþ cells from ROSACreER;YFP;Etv2þ/ (control)
and ROSACreER;YFP;Etv2fl/- (ROSACreEREtv2KO) embryos, indicating that cells that received Cre excision by E9.5 Tmx injection can develop ECs and
HPCs. (B) Fetal liver HPCs from ROSACreER;YFP;Etv2þ/ (control) and ROSACreER;YFP;Etv2fl/- (ROSACreEREtv2KO) embryos were analyzed. Both
control and ROSACreEREtv2KO embryos generated CD45þ/YFPþ cells (upper panels). Comparable proportions of KSL population from control and RO-
SACreEREtv2KO embryos are present as YFPþ cells (lower panels), indicating that Etv2 ablation at E9.5 does not affect HPC progenitor generation, possibly
from hemogenic ECs.
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Supplementary Table E1. Primer sets for quantitative polymerase chain reaction
Fwd 5ʹ–3ʹ Rev 5ʹ–3ʹ
Gata3 ATTAAATAGCTTCTATGCGCCCGGCG ATGCATGTTGGTAGCTGGTACGCT
Lmo2 TCAGCTGTGACCTCTGTGG CACCCGCATCGTCATCTC
Fli1 TGCTGTTGTCGCACCTCAGTTA TGTTCTTGCCCATGGTCTGTG
Myb GCTGCCCAAATCTGGAAAGCGTCA GTCCGGTTGGGCAGATAATTGGCA
Hes1 CTCCTCGCTCACTTCGGACT TAGCAGTGGCCTGAGGCTCT
Notch4 GTTGAAGAATTGATCGCAGCC AGGAAAAGCGGCGTCTGTT
Sox17 AGCTCCAGAAACTGCAGACCAGAA TCCATGAGGTGACATGCTGAGGTT
Scl AGCGCTGCTCTATAGCCTTAGC TCACCCGGTTGTTGTTGGT
Runx1 CCAGGTAGCGAGATTCAACGA CAACTTGTGGCGGATTTGTAAA
Meis1 GCAAAGTATGCCAGGGGAGTA TCCTGTGTTAAGAACCGAGGG
Notch1 CTCAGCATGTGCAGAGTCTACTACC GAGAAGTACTCCCAAGGCCCA
Etv2 CAGAGTCCAGCATTCACCAC AGGAATTGCCACAGCTGAAT
Hoxb4 TTCACTACAATCGCTACCTGACGC GGTGTTGGGCAACTTGTGGTCTTT
Hoxb6 GCTCTACTCGTCTGGCTATGC GTGGGTAATAGGAGGACGCC
Cdx4 TCCATCTGCTGTCCGTGGATTTCA ATGCTTCCGTTTCTCTGCTCCTGT
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